R&D Boston751244320
08:30 AM EST

Medicinal Chemistry

Strategy Meeting East Coast USA 2024

Reinvigorating Productivity in Pharmarn Biotech Through Advanced Technologies and Innovative Techniques that Interrogate Activity and Mechanisms

What makes our strategy meetings unique?


Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.


Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across the East Coast, you can network with peers from different locations, all in one place.


Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.


Solutions to your Problems

We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.


Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.


Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Meet Our Past Facilitators

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Medicinal Chemistry strategy meeting.

Aaron Frank

Director and Head of Computational Chemistry Arrakis Therapeutics

Allen Hopper

Senior Director of Drug Discovery Lucy Therapeutics

Andrew L. Roughton, Ph.D

WuXi AppTec Co., Ltd.

Blaise Lippa

SVP, Molecular Discovery Morphic Therapeutics

Byron DeLaBarre

Chief Technology Officer (CTO) & Head of Platform Pin Therapeutics

Carlos Pedraza

Associate Vice President and Head of Biology (US) Sai Life Science

Ching Kim Tye

mRNA Director, LNP Platform Development Sanofi

Diane Joseph-McCarthy

Executive Director, Bioengineering Technology & Entrepreneurship Center Boston University

Dominic Reynolds

Senior Vice President, Head of Drug Discovery Remix Therapeutics

Dr. Tamsin Mansley

President and Global Head of Application Science Optibrium Inc.

Ed Olhava

Senior Vice President, Preclinical Development IFM Therapeutics

Horst Hemmerle

Chief Scientific Officer Kojin Therapeutics

Ivan Efremov

VP, Head of Medicinal Chemistry Nereid Therapeutics

Jacques Dumas

Chief Scientific Officer Arrakis Therapeutics

Kaicheng Zhu

Head of Operations, Boston Bellen

Kevin Kreutter

Vice President, Drug Discovery Empress Therapeutics

Liang Mao

Senior Director, Head of Developability and Formulation Research WuXi AppTec

Matthew Lucas

VP of Medical Chemistry Third Harmonic Bio

Norman Azoulay

Director – Scientific Products Excelra

Onur Atasoylu

Director, Head of Computational Chemistry Incyte

Richard Heidebrecht

Vice President and R&D Glycologix

Robert Goodnow

Head Drug Discovery Sciences Takeda

Sam Baskaran

Director, Medicinal Chemistry WuXi AppTec

Sejal Patel

Vice President Chemistry Scorpion Therapeutics

Shankar Venkatraman

Executive Director, Chemistry IFM Therapeutics

Sonela Cavicke

Vice President of Discovery Business Development Sai Life Sciences Ltd

Xiaoqi (Charles) Chen

VP of Business Development Bellen Chemistry
See the full agenda and facilitator line-uprnDownload the strategy meeting brochure for full details

Who Should Attend the Event?

Chief Executive Officers

Executive Vice Presidents

Vice Presidents

Executive Directors


Global Heads

Responsible For:

Medicinal Chemist

Computational Chemist



In-Silico/In-vivo/In-vitro Chemist/Biologist

Chemical Biology

Molecular Chemist/Biologist

Hit and Lead Chemist

Small/Large Molecules Chemist

Drug Discovery or Drug Development


See Which Topics Are Discussed at the Strategy Meeting

Reasons To Attend the Strategy Meeting

Discussions on the advancements in targeted protein degradation andrnpushing past its boundaries.

Leveraging Artificial Intelligence and Machine Learning in accelerating therndevelopment of new drugs

Discuss approaches to further understand the interactions of undruggablerntargets and different Protein Degraders such as PROTACs, Molecular Glues,rnetc

Focusing on advancing interrogative techniques to improve the Drug Delivery System/Discovery: Modified mRNA, Nanoparticle-Mediated siRNA, Antibody-Drug Conjugates, and more

Become an official strategy meeting partner Whatever your business needs, we can help. Get in touch for partnering opportunities

Press play to hear what your colleagues had to say…

Hotel & Venue

Le Méridien Boston Cambridge

Le Méridien Cambridge-MIT’s elegant guest rooms and suites offer a place of luxurious sanctuary and unmatched comfort. Explore unique programs inspired by the brand’s European heritage. Born in a glamorous era of travel, Le Méridien believes everyone should explore the world in style.

Hotel Details Maps & Direction Parking

Quick Links

Want to find out more?

Find out more details about our Strategy Meetings and other news and events.

Here To Help

Want to know more? Interested in sponsoring the event? Need help registering your team? Just get in touch and a member of the team will be happy to help.

    I agree to Proventa International storing this information to reply to my query and in accordance with our Privacy Policy.
    You may unsubscribe at any time.